Why PR works better on a daily schedule
Four items a day — a pitch batch, a social push, a reactive item and an evergreen asset — beats one big campaign a quarter. Here is the cadence and the reasoning behind it.
Key takeaways
- Consistency beats intensity: reporters remember the person who is reliably there.
- Reactive items should jump the queue when the news cycle moves.
- Blackout dates and holiday calendars prevent wasted sends.
Most companies do PR in bursts. A launch, a funding round, a conference — then silence for two months. Bursts feel productive because they are visible, but they do not build the thing that earns coverage, which is a relationship with a reporter who knows what you are about.
The alternative is a daily cadence: one pitch batch, one social push, one reactive item and one evergreen asset, every working day. Four small things instead of one enormous thing. Over a quarter that is around two hundred and forty touchpoints, most of them cheap.
The pitch batch is where placement happens. It is a small set of beat-matched sends, released inside a narrow window when inboxes are least crowded, with A/B subject variants so the next batch is better than this one.
The reactive item is the one that jumps the queue. When a headline lands in your category, a response within a few hours is worth more than a polished pitch next week. This is why the scheduler reorders for newsjacks rather than treating them as another slot.
The evergreen asset is the compounding one. A guide, a data page, a definition block — something that keeps earning citations long after it was written, on a surface you own rather than rent.
The social push is the cheap one. Two posts, templated, auto-approvable, keeping the brand present between pitches without consuming a human decision.
None of it works without a gate. Every batch waits for approval, quotes wait for a named human, and any reply, opt-out, bounce or do-not-pitch flag stops the sequence dead. Cadence without consent is just spam at a higher frequency.
Written by PRMagi Research.